2013
DOI: 10.1021/ml4003315
|View full text |Cite
|
Sign up to set email alerts
|

Structure-Based Design of 2-Aminopyridine Oxazolidinones as Potent and Selective Tankyrase Inhibitors

Abstract: Aberrant activation of the Wnt pathway has been implicated in the development and formation of many cancers. TNKS inhibition has been shown to antagonize Wnt signaling via Axin stabilization in APC mutant colon cancer cell lines. We employed structure-based design to identify a series of 2-aminopyridine oxazolidinones as potent and selective TNKS inhibitors. These compounds exhibited good enzyme and cell potency as well as selectivity over other PARP isoforms. Co-crystal structures of these 2-aminopyridine oxa… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
22
0

Year Published

2014
2014
2023
2023

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 29 publications
(22 citation statements)
references
References 24 publications
0
22
0
Order By: Relevance
“…Earlier compounds in the series suffered from moderate cellular potencies and poor oral exposure but further optimization led to improvements, such as with compound 40 (CMP40), which had significantly improved cellular potencies and when dosed orally in mice, had unbound exposure levels over their cellular IC 50 values. This compound series was further optimized by combining features from a dual binder acquired from HTS [ 167 ]. The optimized compound (CMP4) added a hydrogen bond to a glycine (Gly1196 in TNKS1).…”
Section: Tankyrase Inhibitorsmentioning
confidence: 99%
“…Earlier compounds in the series suffered from moderate cellular potencies and poor oral exposure but further optimization led to improvements, such as with compound 40 (CMP40), which had significantly improved cellular potencies and when dosed orally in mice, had unbound exposure levels over their cellular IC 50 values. This compound series was further optimized by combining features from a dual binder acquired from HTS [ 167 ]. The optimized compound (CMP4) added a hydrogen bond to a glycine (Gly1196 in TNKS1).…”
Section: Tankyrase Inhibitorsmentioning
confidence: 99%
“…In a subsequent animal study, compounds 88 and 89 were administered orally to mice bearing DLD-1 tumor. The in vivo efficacy was confirmed by measuring the Wnt-pathway biomarkers [37].…”
Section: Inhibitors By Occupying the Adjacent Adenosine Binding Pocketmentioning
confidence: 89%
“…Recently, the synthesis of structure 134 , based on a 2‐aminopyridine/oxazolidinone scaffold and displaying tankyrase inhibitory activity, with the aid of a Stille reaction was reported by Huang et al (Scheme ) 99. The Stille coupling between 2‐amino‐3‐bromopyridine derivative 132 and 2‐(tributylstannyl)pyrimidine ( 133 ) was performed in the presence of Pd(PPh 3 ) 4 /CuI and LiCl under microwave irradiation conditions, in 47 % yield.…”
Section: C–c Cross‐coupling Reactionsmentioning
confidence: 99%
“… Stille coupling between 2‐amino‐3‐bromopyridine derivative 132 and 2‐(tributylstannyl)pyrimidine ( 133 ) 99…”
Section: C–c Cross‐coupling Reactionsmentioning
confidence: 99%